Literature DB >> 20178825

Structural modifications of nucleosides in ionic liquids.

Vineet Kumar1, Virinder S Parmar, Sanjay V Malhotra.   

Abstract

Nucleoside chemistry represents an important research area for drug discovery, as many nucleoside analogs are prominent drugs and have been widely applied for cancer and viral chemotherapy. However, the synthesis of modified nucleosides presents a major challenge, which is further aggravated by poor solubility of these compounds in common organic solvents. Most of the currently available methods for nucleoside modification employ toxic high boiling solvents; require long reaction time and tedious workup methods. As such, there is constant effort to develop process chemistry in alternative medium to limit the use of organic solvents that are hazardous to the environment and can be deleterious to human health. One such approach is to use ionic liquids, which are 'designer materials' with unique and tunable physico-chemical properties. Studies have shown that methodologies using ionic liquids are highly efficient and convenient for the synthesis of nucleoside analogs, as demonstrated by the preparation of pharmaceutically important anti-viral drugs. This article summarizes recent efforts on nucleoside modification using ionic liquids. Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20178825      PMCID: PMC3214640          DOI: 10.1016/j.biochi.2010.02.019

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  30 in total

1.  Ionic liquid (molten salt) phase organometallic catalysis.

Authors:  Jairton Dupont; Roberto F de Souza; Paulo A Z Suarez
Journal:  Chem Rev       Date:  2002-10       Impact factor: 60.622

2.  Ionic Liquids-New "Solutions" for Transition Metal Catalysis.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-11-03       Impact factor: 15.336

Review 3.  Enantioselective chemo- and bio-catalysis in ionic liquids.

Authors:  Choong Eui Song
Journal:  Chem Commun (Camb)       Date:  2003-10-08       Impact factor: 6.222

Review 4.  L-nucleoside enantiomers as antivirals drugs: a mini-review.

Authors:  Christophe Mathé; Gilles Gosselin
Journal:  Antiviral Res       Date:  2006-05-23       Impact factor: 5.970

5.  Nucleosides. IX. The formation of 2',2'-unsaturated pyrimidine nucleosides via a novel beta-elimination reaction.

Authors:  J R Horwitz; J Chua; M A Da Rooge; M Noel; I L Klundt
Journal:  J Org Chem       Date:  1966-01       Impact factor: 4.354

6.  Ionic liquid as catalyst and reaction medium. The dramatic influence of a task-specific ionic liquid, [bmIm]OH, in Michael addition of active methylene compounds to conjugated ketones, carboxylic esters, and nitriles.

Authors:  Brindaban C Ranu; Subhash Banerjee
Journal:  Org Lett       Date:  2005-07-07       Impact factor: 6.005

7.  Synthesis of nucleoside-based antiviral drugs in ionic liquids.

Authors:  Vineet Kumar; Sanjay V Malhotra
Journal:  Bioorg Med Chem Lett       Date:  2008-08-29       Impact factor: 2.823

8.  5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells.

Authors:  Walter A Cristofoli; Leonard I Wiebe; Erik De Clercq; Graciela Andrei; Robert Snoeck; Jan Balzarini; Edward E Knaus
Journal:  J Med Chem       Date:  2007-05-23       Impact factor: 7.446

9.  Alkyl addition reaction of pyrimidine 2'-ketonucleosides: synthesis of 2'-branched-chain sugar pyrimidine nucleosides (nucleosides and nucleotides. LXXXI.

Authors:  A Matsuda; H Itoh; K Takenuki; T Sasaki; T Ueda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1988-03       Impact factor: 1.645

10.  Ionic liquid promoted preparation of 4H-thiopyran and pyrimidine nucleoside-thiopyran hybrids through one-pot multi-component reaction of thioamide.

Authors:  Xinying Zhang; Xiaoyan Li; Xuesen Fan; Xia Wang; Dongfang Li; Guirong Qu; Jianji Wang
Journal:  Mol Divers       Date:  2008-12-09       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.